AAIC 2025 Abstract

Clinical evaluation of the safety and efficacy of lecanemab treatment in early AD patients in Southeast China (a multicenter cohort study)

Study in peopleInterventions

Abstract

Background: This multicenter study aims to describe efficacy and clinical safety of early Alzheimer's disease (AD) patients receiving lecanemab, and examine the dynamic changes of biomarker characteristics based on blood in real‐world settings.

The paper

First Affiliated Hospital Zhejiang University; Zhejiang University

AAIC 2025 Abstract, 25 Dec 2025, CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70857_101471